Apoptosis‐inducing effects of dBET6 on LSC were seen in patients with CP CML, BP CML, and TKI‐resistant CML cells expressing BCR::ABL1 T315I or BCR::ABL1 F317L. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.